BR100 Increased By (0.63%)
BR30 Increased By (0.86%)
KSE100 Increased By (0.68%)
KSE30 Increased By (0.74%)
AGHA 6.50 Increased By ▲ 0.12 (1.88%)
BECO 4.34 Decreased By ▼ -0.01 (-0.23%)
BML 62.25 Decreased By ▼ -0.30 (-0.48%)
BOP 31.50 Increased By ▲ 0.11 (0.35%)
CNERGY 11.84 Increased By ▲ 0.11 (0.94%)
CSIL 5.97 Increased By ▲ 0.06 (1.02%)
FCCL 61.75 Increased By ▲ 0.04 (0.06%)
FFL 14.87 Increased By ▲ 0.08 (0.54%)
FNEL 1.29 Increased By ▲ 0.05 (4.03%)
KEL 6.35 Increased By ▲ 0.03 (0.47%)
KOSM 5.91 Increased By ▲ 0.01 (0.17%)
LOTCHEM 24.88 Increased By ▲ 0.19 (0.77%)
MLCF 105.00 Increased By ▲ 1.07 (1.03%)
NBP 174.25 Increased By ▲ 0.93 (0.54%)
NCPL 52.10 Increased By ▲ 0.27 (0.52%)
NPL 54.51 Increased By ▲ 0.48 (0.89%)
OGDC 319.50 Increased By ▲ 3.63 (1.15%)
PACE 9.31 Increased By ▲ 0.05 (0.54%)
PAEL 36.00 Increased By ▲ 0.42 (1.18%)
PIBTL 13.78 Increased By ▲ 0.12 (0.88%)
PPL 228.10 Increased By ▲ 2.03 (0.9%)
PRL 81.10 Increased By ▲ 0.82 (1.02%)
PTC 47.24 Increased By ▲ 0.60 (1.29%)
SSGC 24.05 Increased By ▲ 0.23 (0.97%)
TBL 9.31 Increased By ▲ 0.07 (0.76%)
TELE 7.55 No Change ▼ 0.00 (0%)
TPL 25.00 Increased By ▲ 0.46 (1.87%)
TPLP 13.05 Increased By ▲ 0.06 (0.46%)
TREET 26.10 Increased By ▲ 0.12 (0.46%)
TRG 53.60 Increased By ▲ 0.27 (0.51%)
Markets

China stocks gain as country approves first CAR-T cell therapy

  • The yuan was quoted at 6.4807 per US dollar, 0% firmer than the previous close of 6.481.
Published Updated
By

SHANGHAI: China shares rose on Wednesday, with healthcare stocks leading the gains after the country approved its first CAR-T cell therapy, while investors cheered the Federal Reserve's assurance that the US central bank will not hasten to hike rates.

** At the midday break, the Shanghai Composite index was up 0.46% at 3,573.61 points, rising for the third consecutive day. China's blue-chip CSI300 index was up 0.77%.

** The financial sector sub-index climbed 0.13%, the consumer staples sector was down 1.24%, while the real estate index added 0.13%.

** Chinese H-shares listed in Hong Kong rose 1.43% to 10,619.02, while the Hang Seng Index was up 1.46% at 28,721.85.

** The smaller Shenzhen index was up 0.81%, the start-up board ChiNext Composite index advanced 1.63%, and Shanghai's tech-focused STAR50 index climbed 1.53%?.

** The largest percentage gainers in the main Shanghai Composite index were Liaoning SG Automotive Group Co Ltd, up 10.1%, followed by Anhui Jianghuai Automobile Group Corp Ltd , gaining 10.05%.

** Shanghai-listed shares of Shanghai Fosun Pharmaceutical Group Co Ltd rose as much as 3.4% after China approved the first CAR-T cell therapy in the country as a joint venture of Fosun Pharmaceutical had obtained the rights to sell the therapy in China.

** Leading the gains, the healthcare sub-index rose 1.11%.

** Lifting investors' risk appetite was Fed chief Jerome Powell's reassurance of the goal of a broad labour market recovery while he also said fear of inflation alone would not be enough to prompt rate rises.

** China's state planner said on Wednesday that it and the market regulator have recently sent teams to various areas to look into commodities prices and supplies and would learn about mid- and downstream companies' situations.

** Around the region, MSCI's Asia ex-Japan stock index was firmer by 0.74% while Japan's Nikkei index was up 0.02%.

** The yuan was quoted at 6.4807 per US dollar, 0% firmer than the previous close of 6.481.

Comments

Comments are closed for this article.